Tumor Differentiation as a Prognostic Marker in Clinically Staged T1bN0 Esophageal Adenocarcinoma.
Margalit O, Shacham-Shmueli E, Strauss G, Yang YX, Lawrence YR, Ben Nun A, Levy I, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Mamtani R, Boursi B.
Margalit O, et al.
Cancer Invest. 2023 Sep;41(8):734-738. doi: 10.1080/07357907.2023.2255907. Epub 2023 Sep 4.
Cancer Invest. 2023.
PMID: 37665657